Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway

Cancer Science

Volumn 100, Issue 6, 2009, Pages 1051-1061

  He, Yin Yan ^a   Cai, Bin ^a   Yang, Yi Xia ^a   Liu, Xue Lian ^a   Wan, Xiao Ping ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; ESTROGENIC G PROTEIN COUPLED RECEPTOR 30; G PROTEIN COUPLED RECEPTOR; G1 HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ESTROGEN; GPER PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PRIMER DNA;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER TISSUE; CARCINOGENESIS; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; CELL DIVISION; ENDOMETRIUM; ENDOMETRIUM TUMOR; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION; TUMOR CELL LINE;

CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; INTERLEUKIN-6; MAP KINASE KINASE 1; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 67649888455     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01148.x     Document Type: Article

References (36)

1. Hewitt SC, Deroo BJ, Korach KS. A new mediator for an old hormone?. Science 2005, 307:1572-3.
2. Shang Y. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nature Rev Cancer 2006, 6:360-8.
3. Pietras RJ, Levin ER, Szego CM. Estrogen receptors and cell signaling. Science 2005, 310:51-3.
4. Thornton JW, Need E, Crews D. Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Science 2003, 301:1714-17.
5. Revankar CM, Cimino DF, Sklar LA. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-30.
6. Filardo EJ, Quinn JA, Bland KI. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000, 14:1649-60.
7. Filardo EJ, Quinn JA, Frackelton Jr. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 2002, 16:70-84.
8. Wang C, Prossnitz ER, Roy SK. Expression of G protein-coupled receptor 30 in the hamster ovary: differential regulation by gonadotropins and steroid hormones. Endocrinology 2007, 148:4853-64.
9. Baquedano MS, Saraco N, Berensztein E. Identification and developmental changes of aromatase and estrogen receptor expression in prepubertal and pubertal human adrenal tissues. J Clin Endocrinol Metab 2007, 92:2215-22.
10. Hsieh YC, Yu HP, Frink M. G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma-hemorrhage. Am J Pathol 2007, 170:1210-18.
11. Carmeci C, Thompson DA, Ring HZ. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 1997, 45:607-17.
12. Vivacqua A, Bonofiglio D, Recchia AG. The G protein coupled receptor GPR30 mediates the proliferative effects induced by 17β-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 2006, 20:631-46.
13. Albanito L, Madeo A, Lappano R. G protein coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 2007, 67:1859-66.
14. Vivacqua A, Bonofiglio D, Albanito L. 17β-Estradiol, genistein and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30. Mol Pharmacol 2006, 70:1414-23.
15. Benedet JL, Bender H, Jones H 3rd. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000, 70:209-62.
16. Yoshizaki T, Sato H, Maruyama Y. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer 1997, 79:139-44.
17. Di Cristofano A, Ellenson LH. Endometrial carcinoma. Annu Rev Pathol 2007, 2:57-85.
18. Cai B, Liu L, Wan XP. Comparison of the molecular classification with FIGO stage and histological grade on endometrial cancer. Eur J Gynaecol Oncol 2007, 28:451-60.
19. Migliaccio A, Di Domenico M, Castoria G. Tyrosine kinase/p21ras/MAPkinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996, 15:1292-300.
20. Martin MB, Franke TF, Stoica GE. A role for AKT in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 2000, 141:4503-11.
21. Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 2002, 80:231-8.
22. Burnette WN, Koff WC, Six HR. Perspectives in recombinant pertussis toxoid development. Vaccine Research and Development 1992, 143-96. In, eds, New York, Marcel Dekker
23. Naugler WE, Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 2008, 14:109-19.
24. Bellone S, Watts K, Cane' S. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer. Gynecol Oncol 2005, 98:92-8.
25. Thomas P, Pang Y, Filardo EJ. Identity of an estrogen membrane receptor coupled to a G-protein in human breast cancer cells. Endocrinology 2005, 146:624-32.
26. Funakoshi T, Yanai A, Shinoda K. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun 2006, 346:904-10.
27. Saini DK, Kalyanaraman V, Chisari M. A family of G protein βγ subunits translocate reversibly from the plasma membrane to endomembranes on receptor activation. J Biol Chem 2007, 282:24 099-108.
28. Smith HO, Leslie KK, Singh M. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 2007, 196:386-9.
29. Filardo EJ, Graeber CT, Quinn JA. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 2006, 12:6359-66.
30. Wang C, Prossnitz ER, Roy SK. Expression of GPR30 in the hamster ovary: differential regulation by gonadotropins and steroid hormones. Endocrinology 2007, 554:4853-64.
31. Prossnitz ER, Arterburn JB, Sklar LA. GPR30: a G protein-coupled receptor for estrogen. Mol Cell Endocrinol 2007, 265-266:138-42.
32. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-74.
33. Syed V, Ulinski G, Mok SC. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells. J Natl Cancer Inst 2002, 94:617-29.
34. Sriuranpong V, Park JI, Amornphimoltham P. Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res 2003, 63:2948-56.
35. Giri D, Ozen M, Ittmann M. Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol 2001, 159:2159-65.
36. Ariazi EA, Ariazi JL, Cordera F. Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem 2006, 6:181-202.